Brief: Sprint Bioscience Achieves First Preclinical Sub-Target
June 3 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* FIRST PRECLINICAL SUB-TARGET WAS ACHIEVED
* GETS SUB-TARGET PAYMENT OF USD 1.5 MILLION
Source text for Eikon: ID:nWkr5jwp9y
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln